0,1,2,3,4,5
Table 14: Intracavernous injection therapy - compounds and characteristics,,,,,
Name,Substance,Dosage,Efficacy,Adverse Events,Comment
"Caverject™ or 
Edex/Viridal™",Alprostadil,5-40 μg/mL,~ 70%,"Penile pain, 
priapism, fibrosis",Easily available
Papaverine,Papaverine,20 - 80 mg,< 55%,"Elevation of liver 
enzymes, priapism, 
fibrosis","Abandoned as 
monotherapy"
Phentolamine,Phentolamine,0.5 mg/mL,"Poor 
efficacy as 
monotherapy","Systemic 
hypotension, reflex 
tachycardia, nasal 
congestion, and 
gastrointestinal 
upset","Abandoned as 
monotherapy"
Bimix,"Papaverine + 
Phentolamine","30 mg/mL + 
0.5 mg/mL",~ 90%,"Similar to 
Alprostadil (less 
pain)","Not licensed for 
the treatment 
of ED"
Trimix,"Papaverine + 
Phentolamine + 
Alprostadil","30 mg/mL + 
1 mg/mL + 
10 μg/mL",~ 92%,"Similar as 
Alprostadil (less 
pain)","Not licensed for 
the treatment 
of ED"
Invicorp™,"Vasoactive 
intestinal 
peptide (VIP) + 
Phentolamine",25 μg + 1-2 mg,~ 80%,"Similar as 
Alprostadil without 
pain",Easily available
